MBioS PSM Degree - Advisory Board
Director of PSM, Assistant Director Distance Degree Program, Clinical Associate Professor, SMB
Norah McCabe is a Clinical Associate Professor in the School of Molecular Biosciences (SMB) and is the Director of the PSM. She also serves as the Assistant Director of online Molecular Biosciences courses within SMB. Dr McCabe has been a faculty member at WSU for 15 years where she teaches courses in Genetics and Introductory Biology both online and on-campus. Her research interests are in human genetic diseases in particular the genetics of cancer cells. Dr McCabe’s educational background reflects her interest in interdisciplinary education as she has degrees in Pharmacology and Neurochemistry, with post-doctoral research in human genetic diseases. Dr McCabe has worked on the development of this new Master’s option, as she recognizes the demand of interdisciplinary training in workplace readiness and adaptability for current and future employees in the ever growing global workplace.
Associate Graduate Director, School of Molecular Biosciences
Dr. Watts was appointed to the position of Associate Director of the Graduate Program in the School of Molecular Biosciences (SMB) during summer 2017. She has been a faculty member in SMB at WSU for 10 years where she teaches the undergraduate Genetics Lab course and supervises a research lab. Her research program addresses the physiological functions of unsaturated fats in animal development and stress responses.
Professor, College of Veterinary Medicine Integrative Physiology and Neuroscience
Dr. Harding is an internationally recognized expert on the neurochemistry of angiotensin peptides and their receptors and the development of peptide-based pharmaceuticals. Dr. Harding was an American Heart Association Established Investigator from 1985-1990, an NIH Fogarty fellow, and he has served on peer review committees for the NIH, NSF, and the American Heart Association. He has published more than 225 scientific articles and chapters on brain angiotensin, neurodegenerative disease, and cancer; and he reviews submitted manuscripts for 40+ scientific journals concerned with topics in the neurosciences, neurochemistry and biotechnology. In addition Dr. Harding has founded several biotechnology companies one of which has drug candidates in development for Alzheimer’s and Parkinson’s diseases. Dr. Harding received his Ph.D. in chemistry from the University of Delaware in 1974 and completed his postdoctoral work in neurochemistry at the Roche Institute for Molecular Biology in Nutley, N.J. from 1974-76. He moved to WSU in 1976 and was promoted to Full Professor in 1985. His research includes understanding and developing pharmaceuticals to treat dementia, cancer, and deficits in wound healing.
Assistant Professor, School of Politics, Philosophy, and Public Affairs, Co-director of ethics at Pullman Regional Hospital
Dr. Kabasenche earned his Ph.D. in Philosophy from the University of Tennessee in 2006. His research includes bioethics, ethics (virtue ethics, moral psychology), and the emergence of biomedical technologies and how it affects character and identity. He currently teaches courses in bioethics, biomedical ethics, and ethics of social science research.
CEO and Co-Founder of BowTie.io
Scott is the CEO and Co-Founder of BowTie.io, an internet tech company focused on providing the fastest, most innovative static hosting platform for developers. Prior to BowTie.io, Scott was VP of Strategy and Operations for @Pay, a mobile payment startup where he led the @Pay Product and Production teams, as well as provided direct leadership for all strategic initiatives. Before that he was Senior Operations and Strategy Manager for LivingSocial, where he was responsible for leadership of several operational and strategic teams, and a key driver of growth for one of the company’s fastest growing divisions. At Human Genome Sciences he ran finance throughout R&D prior to the company’s sale to GlaxoSmithKline. As a finance lead to the Emerging Markets Unit at Pfizer, Scott provided business development and financial efforts for nearly $400M in partnerships deals and international operations. Scott is a third generation entrepreneur, sits on the board of several companies, consults for clients around the country (both Fortune 500 and startups), and guest lectures on business strategy and innovation at universities and conferences.
Ph.D. Analytical Chemistry - University of Rhode Island
B.S. Chemistry - Washington State University
Dr. Shane Needham received his B.S. degree in chemistry from Washington State University and his Ph.D. in chemistry from the University of Rhode Island. Dr. Needham is Laboratory Director of Alturas Analytics, Inc. Dr. Needham manages all scientific aspects of the HPLC/MS/MS bioanalytical contract laboratory at Alturas Analytics, Inc. Currently, Dr. Needham’s work is focused on the development and validation of assays for the determination of therapeutic agents and biomarkers from biological matrices. His laboratory has been a leader in the area of dried blood spot (DBS) analysis and microflow HPLC-MS/MS to support DMPK research.
Dr. Needham has over 100 publications and external presentations in the area of LC/MS. He has over 20 years of LC/MS and analytical lab experience in the drug discovery through drug development stage in the pharmaceutical industry. He previously worked for Pfizer in Groton, CT where he developed and validated GLP and non-GLP LC/MS/MS methods for the trace analysis of drugs and metabolites in biological fluids. He also performed in vivo and in vitro structure elucidation studies of drugs and metabolites using HPLC/MS/MS and HPLC/MSn instrumentation. Dr. Needham has LC/MS experience working with triple quadrupole, single quadrupole, ion trap, time-of-flight and quadrupole time-of-flight instrumentation. His area of academic research included the development of optimized stationary phases to improve the assay of pharmaceuticals by HPLC/MS.
Dr. Needham has been the chair and organizer of several workshops at national conferences. Dr. Needham also teaches LC/MS courses at international conferences including, Pittcon and AAPS conferences. Dr. Needham is also a reviewer for several peer reviewed journals including, Bioanalysis, Journal of Chromatography, Analytical Chemistry and Journal of Chromatographic Science. Dr. Needham also serves on the editorial board for the publication, American Pharmaceutical Review. Dr. Needham is a member of the American Chemical Society, American Society for Mass Spectrometry, American Association of Pharmaceutical Scientists and the International Society of the Study of Xenobiotics.
Professor Emeritus, Ag Econ, and President of Belrose Inc.
Dr O’Rourke is a native of Northern Ireland. He has undergraduate degrees in Classics from Queens University, Belfast, and in Commerce from University College, Dublin and an M.A. and PhD in Agricultural Economics from the University of California, Davis. He served on the Agricultural Economics faculty of Washington State University from 1970 to 2000 and headed their international marketing program from 1985 to 2000 when he moved to the private sector to set up his own consulting company, Belrose, Inc., world fruit market analysts. That company publishes the monthly World Apple Report and other annual reviews of global fruit markets. Dr O’Rourke is the author of over 200 publications and a frequent invited speaker around the world on various aspects of food marketing and international trade. He and his wife have three grown children and three grandchildren.
Dr O'Rourke is a strong supporter of the PSM program because he believes that the future competitiveness of American business depends on having leaders with a strong training in both science and management.
Founder and CEO - Paw Print Genetics, a division of Genetic Veterinary Sciences, Inc. - Spokane, WA
Dr. Shaffer received her B.S in Biology at Washington State University in 1984 and completed her Ph.D. in Human Genetics in 1990 from the Medical College of Virginia, Virginia Commonwealth University, Richmond. She was an adjunct professor in the School of Molecular Biosciences from 2009-2017. After spending over 20 years in human genetics and developing technologies to improve diagnostic testing, she took that knowledge to inherited diseases of dogs. Paw Print Genetics is dedicated to providing state-of-the-art diagnostics for over 170 canine conditions for more than 350 breeds of dogs.
Jean Paul Tousignant
PSM in Molecular Biosciences
Jean Paul Tousignant has worked in Molecular Diagnostic sales for 25 years, with companies such as Gen-Probe, Cepheid and Roche Diagnostics. He is a 2013 graduate of the Molecular Biosciences PSM Degree at Washington State University.
After a recent one year stint in Pharmaceutical consulting, he has returned to the Diagnostics field as a Clinical Specialist with Illumina. Jean Paul joined the PSM Advisory Board in 2015 and provides a unique perspective of the PSM program in the workplace for his fellow board members.